VIS - TechWire

VIS

2025.09.02

15:43

Beilu Pharmaceutical: Haichang Pharmaceutical passed the GMP certification of the Brazilian National Health Surveillance Agency

Beilu Pharmaceutical announced that its controlling subsidiary, Haichang Pharmaceutical, recently passed the official on-site GMP certification from the Brazilian National Health Surveillance Agency (ANVISA). The certification covers the product iohexol, with the certification number 0137263/24-4. This certification lays a solid foundation for Haichang Pharmaceutical's successful entry into the Brazilian market and further expansion into other international markets, and is of positive significance to the Group's overall internationalization strategy.

2025.08.05

16:18

ST Nuotai: passed the pharmaceutical cGMP on-site inspection

ST Notech announced that it recently received its CBPF-GMP certificate, issued by the Brazilian National Health Surveillance Agency (ANVISA), a member of the PIC/S (Public Health and Medical Products Administration). This inspection covered the company's Lianyungang facility's cGMP system, which produces the APIs semaglutide and liraglutide. This on-site cGMP inspection by ANVISA marks the first time the company's semaglutide and liraglutide API production lines have passed official overseas compliance inspections, following those by the U.S. Food and Drug Administration (FDA) and the Ministry of Food and Drug Safety (MFDS) of South Korea.

2025.07.16

15:42

Bio-Thera: BAT2506 (golimumab) injection marketing authorization application accepted by the U.S. FDA

Bio-Thera announced that the company recently received a notice that the U.S. Food and Drug Administration (FDA) accepted the biologics license application (BLA) for BAT2506 (golimumab) injection. The drug is a biosimilar to golimumab, and the original drug is Simponi (Ximponi) of Johnson & Johnson, with global sales of US$2.19 billion in 2024. Bio-Thera has cooperated with many companies to carry out the commercialization process of BAT2506 (golimumab) injection in multiple regions. The drug marketing authorization application has been accepted by China NMPA, US FDA, European EMA, and Brazilian ANVISA.

2025.06.27

18:51

Rundu shares: passed the GMP certification of the Brazilian National Health Surveillance Agency

Rundu shares announced that the company accepted the on-site GMP certification of the Brazilian National Health Surveillance Agency from March 17, 2025 to March 21, 2025, and the certification scope was chemical raw materials: candesartan cilexetil, sacubitril valsartan sodium, telmisartan, and valsartan. Recently, the company received two GMP certification certificates issued by Brazil's ANVISA, which are valid until May 26, 2027 and June 9, 2027. The conclusion of the on-site inspection by Brazil's ANVISA is qualified, that is, the company's four raw material products have passed the Brazilian ANVISA on-site GMP certification.

2025.06.04

18:31

The AI competition in gaming is heating up. Tencent, Mihoyo, and NetEase are showing off their technology trump cards

Tencent Games has created a game creation AI full-link solution business called "VISVISE", which includes development tools such as Auto LUV and skirt AI created by the GoSkinning team of its product performance department, and various AI game tools are under intensive development. Not long ago, Tencent Hunyuan also released the Hunyuan game visual generation platform. It is reported that the platform is the first industrial-grade AIGC game content production engine built on the Hunyuan large model, which can greatly optimize the game asset generation and game production process. For example, in the case given by the Hunyuan game team, the Hunyuan game platform can accurately restore professional terms such as "thick coating", "celluloid", and "cyberpunk", and supports high consistency generation of various mainstream game styles and themes such as realism, cartoons, and oriental mythology. AI is becoming a new engine for Tencent's game business. In this year's first quarter earnings call, Tencent CEO Ma Huateng said that in the first quarter, Tencent's AI capabilities have made substantial contributions to businesses such as Evergreen Games. Not only Tencent, but also NetEase and Mihayou have increased their AI game layouts.

2025.04.30

04:20

VISA's second-quarter net revenue of $9.59 billion is higher than market expectations

VISA's second-quarter net revenue was $9.59 billion, compared with an estimated $9.55 billion; second-quarter adjusted earnings per share were $2.76, compared with an estimated $2.68.

2025.04.11

04:21

TRUMP TRADE ADVISER NAVARRO: YIELDS COMING DOWN IS GREAT NEWS

04:20

TRUMP TRADE ADVISER NAVARRO: THE DROP IN THE MARKET TODAY IS NO BIG DEAL

04:17

TRUMP TRADE ADVISER NAVARRO: INDIA, AUSTRALIA, AND THE UK ARE ALL COMING IN, GOING TO GET DEALS

2025.03.31

10:33

China Science and Technology Star Map releases low-altitude intelligent navigation platform to build a low-altitude application service system

According to China Science and Technology Star Map, China Science and Technology Star Map recently officially released the GEOVIS iFlight low-altitude intelligent flight application platform v1.0, helping to accelerate the arrival of the intelligent low-altitude era of "one city, one network, one aircraft, multiple functions, and one map, multiple uses". The low-altitude intelligent flight platform is centered on "software and hardware integration", integrating drone hardware, intelligent algorithms and cloud management and control systems to build a low-altitude application service system covering all scenarios.

2025.02.28

15:53

Zeiss's new generation of all-femtosecond equipment has been approved for sale in the country

Zeiss announced that the new generation of all-femtosecond device VISUMAX800 and innovative minimally invasive surgery SMILEpro have been officially approved by the China National Medical Products Administration for marketing. VISUMAX800 was unveiled during the Shanghai International Import Expo last year. It has a 2MHz laser pulse frequency and can produce corneal lenses within 10 seconds, greatly improving surgical efficiency.

2025.02.25

14:17

China-Qatar Entrepreneurs Exchange Meeting and the 3rd Chain Expo Promotion were successfully held in Doha, Qatar

On February 24th local time, the China-Qatar Entrepreneurs Exchange Conference and the 3rd Chain Expo Promotion were successfully held in Doha, Qatar. Guests attending the meeting said that China-Qatar economic and trade cooperation has huge potential and broad prospects. China's trade structure with Qatar is also continuously optimizing. China-Qatar cooperation has made remarkable progress in areas such as new energy and high-end equipment manufacturing. The consumption structure has been further optimized, pushing China-Qatar cooperation to a higher level. Qatari companies and institutions will actively participate in the third Chain Expo to build a stable and mutually trusting industrial chain and supply chain partnership. This exchange meeting will focus on promoting the third Chain Expo. Enterprises and institutions such as the China-Qatar Free Zone Industrial Park, Qatar GORD ADVISORY Consulting Company, and Ningxia Council for the Promotion of International Trade made on-site presentations. Enterprises and institutions from both China and Qatar actively carried out business negotiations and reached a number of contract signings.

2025.02.21

00:36

VISA CEO: Stablecoin transaction volume has increased by 40% in the past two years.

2025.02.11

21:16

Anko Bio: Plans to use no more than US$31 million of its own funds to participate in Weisheng Pharmaceutical's Hong Kong initial public offering

Anko Bio announced that the company plans to use its own funds of no more than US$31 million through its wholly-owned subsidiary Anko Bio (Hong Kong) Co., Ltd. to participate as a cornerstone investor in the subscription of VISEN Pharmaceuticals' initial public offering shares issued on the Hong Kong Stock Exchange and sign a "Cornerstone Investment Agreement". Weisheng Pharmaceuticals is a late-stage biopharmaceutical company with products close to commercialization, focusing on providing treatment solutions for specific endocrine diseases in China (including Hong Kong, Macau and Taiwan).

2025.01.28

23:01

CEO of social media platform "X": XMONEY accounts will be launched later this year, and VISA is the first partner.

Email Subscription

Newsletters and emails are now available! Delivered on time, every weekday, to keep you up to date with North American business news.

Weekly Highlights

                                    A Republican lawmaker is seeking to halt all federal funding to New York City following the election of Zohran Mamdani as mayor
                            2025-11-09

                                    Supreme Court Pause on SNAP Benefits: Market Ripples, Policy Shock & Ticker Watch
                            2025-11-12

                                    After $2,000 Payments, Remaining Revenue to Slash National Debt
                            2025-11-16

                                    Trump Administration’s 50-Year Mortgage Gamble: What It Means for Housing, Builders and the Options Market
                            2025-11-12

                                    Gen Z expects to inherit money and assets—but their boomer parents aren’t planning on leaving anything behind
                            2025-11-11